Squarepoint’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$21.4M Buy
72,600
+63,800
+725% +$19M 0.03% 672
2025
Q4
$2.4M Sell
8,800
-25,200
-74% -$6.85M ﹤0.01% 1932
2025
Q3
$9.19M Sell
34,000
-104,400
-75% -$28.4M 0.01% 1117
2025
Q2
$38.1M Sell
138,400
-1,600
-1% -$435K 0.04% 484
2025
Q1
$37.1M Buy
140,000
+84,500
+152% +$20.8M 0.05% 438
2024
Q4
$12.9M Buy
55,500
+40,400
+268% +$9.29M 0.01% 1002
2024
Q3
$3.33M Sell
15,100
-17,900
-54% -$3.7M 0.01% 1716
2024
Q2
$6.49M Buy
33,000
+25,000
+313% +$5.17M 0.01% 1200
2024
Q1
$1.72M Buy
8,000
+500
+7% +$105K ﹤0.01% 2187
2023
Q4
$1.58M Buy
7,500
+6,100
+436% +$1.3M ﹤0.01% 2183
2023
Q3
$280K Buy
+1,400
New +$278K ﹤0.01% 3207
2021
Q4
Sell
-21,900
Closed -$4.24M 3205
2021
Q3
$4.24M Sell
21,900
-15,700
-42% -$3.18M 0.01% 852
2021
Q2
$8M Buy
37,600
+32,700
+667% +$6.9M 0.03% 542
2021
Q1
$1M Sell
4,900
-27,800
-85% -$5.48M 0.01% 1492
2020
Q4
$5.95M Buy
+32,700
New +$5.56M 0.04% 415

Other funds holding CME

Squarepoint's CME Position: Q1 2026 in Review

Squarepoint increased its CME Group (CME) stake by 122% in Q1 2026, buying an estimated $19.8M and bringing the position to 121,196 shares worth $35.8M. The position accounts for 0.04% of the portfolio, ranked #447.

Squarepoint first reported a position in CME in Q2 2015 and has held it in 42 quarters since. The position peaked at $72.7M in Q4 2022. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Squarepoint held 121,196 shares of CME Group worth $35.8M as of Q1 2026.
  • Squarepoint bought 66,586 CME Group shares in Q1 2026, an estimated $19.8M.
  • CME Group made up 0.04% of Squarepoint's portfolio in Q1 2026, its #447 holding.
  • Squarepoint first reported a position in CME Group in Q2 2015 and has held it in 42 quarters since.
  • Squarepoint's CME Group position peaked at $72.7M in Q4 2022.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.